Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
55 /100
HIGH RISK
Score updated Oct 13, 2026

GTBP — GT Biopharma, Inc. Dilution Risk Tracker

Track GTBP dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GTBP — Get alerts when the score changes →

As of October 13, 2026, GT Biopharma, Inc. (GTBP) has a DilutionWatch DilutionScore of 55/100, rated HIGH dilution risk. GT Biopharma, Inc. has a market capitalization of $306.74M, 45.11M shares outstanding, 41 institutional holders tracked. Stored dilution-related fields include 400.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊 Float Risk
22
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 27%
🔄 Reverse Split model est. 55%
• 50-day avg $0.39 below $1 exchange minimum
🔔 Track GTBP — Get forecast alerts →

Market Data

Market Cap$306.74M
Shares Outstanding45.11M
Float33.53M
Cash$12.82M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore55/100DilutionWatch score record
Shares Outstanding45.11MVerified float table or market cache
Public Float33.53MVerified float table or market cache
Market Cap$306.74MMarket data cache
Cash Runway13.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants400.0KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 424B3 1, EFFECT 1, S-1 2, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 329.9% shares (2026Q1 vs prior)
41 institutional holders · 2.08M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 903.8K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 294.5K shares
#3 VANGUARD FIDUCIARY TRUST CO 225.9K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest259.4K
Days to Cover4.4
% of Float0.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-14
xbrl XBRL CONVERTIBLE 2024-03-26
S-1 SHELF 2026-04-30
424B3 ATM 2026-01-30
EFFECT EFFECT 2026-01-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual GTBP Dilution Snapshot

GT Biopharma, Inc. (GTBP) has a DilutionScore of 55/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

GTBP's DilutionScore is currently 55/100 (High risk), with 4 score changes tracked over 89 days. The score deteriorated from 56/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202655/100HIGH13 days
Aug 22 – Sep 30, 202656/100HIGH40 days
Aug 14 – Aug 21, 202661/100HIGH7 days
Jul 17 – Aug 13, 202654/100HIGH28 days
Jul 16, 202653/100HIGH1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

GTBP shares outstanding have increased 1.2% from 35.62M (May 2026) to 36.06M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 202636.06M33.53M▲ 1.09%
May 17, 202635.62M33.17M▲ 7.60%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track GTBP Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment GTBP files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking GTBP — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GTBP
GTBP FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.